Travere Therapeutics Reports Second Quarter 2023 Financial Results
Go back to Travere Therapeutics Reports Second Quarter 2023 Financial Results| (NASDAQ: TVTX) | Delayed: 65.71 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $65.71 | 52 Week High | $ | |||
| Open | $65.71 | 52 Week Low | $ | |||
| Day High | $65.71 | P/E | N/A | |||
| Day Low | $65.71 | EPS | $ | |||
| Volume | 6,441 | |||||

